Journal of Hematology & Thromboembolic Diseases

ISSN: 2329-8790

Journal of Hematology & Thromboembolic Diseases
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year
across USA, Europe & Asia with support from 1000 more scientific Societies and
Publishes 700+ Open Access Journals which contains over 50000
eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers
Each Journal is getting 25,000+ Readers
This Readership is 10 times more when compared to other
Subscription Journals (Source: Google Analytics)
 
 
 
 
 
 
 

Editorial Board

Editor Image

J. J. Michiels
Goodheart Institute and Foundation
Netherlands

Editor Image

Anand P Jillella
Georgia Regents University Cancer Center
USA

Editor Image

Mojtaba Akhtari
University of Nebraska Medical center
USA

Editor Image

Peter H Norman
University of Texas Anderson Cancer Center
USA

View More»
 

Submit Manuscript

Journal Impact Factor 0.818*
Submit manuscript at http://www.editorialmanager.com/biomedicaljournals/ or send as an e-mail attachment to the Editorial Office at editor.jhtd@omicsonline.com

About the Journal

Journal of Hematology & Thromboembolic Diseases is a peer reviewed medical journal that includes a wide range of fields in its discipline to create a platform for the authors to make their contribution towards the journal. The editorial office promises a thorough peer review of the submitted manuscripts to ensure quality.
This is one of the best open access journals that aims to publish the most complete and reliable source of information on discoveries and current developments as original articles, review articles, case reports, short communications, etc. in the field and provides online access without any restrictions or subscriptions to researchers worldwide.
Journal of Hematology and Thromboembolic Diseases is a peer reviewed journal, serving the International Scientific Community. This Hematology journal offers an open access platform to the authors to publish their research outcome.

OMICS International organizes 1000+ conferences every year across USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ scholarly open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

Aims and Scope

 

Anemia

Anemia is a therapeutic condition in which the red platelet cells or hemoglobin is not as much as ordinary. Anemia is brought on by either a lessening underway of red platelets or hemoglobin, or an increment in misfortune or devastation of red platelets. Anemia is the most widely recognized issue of the blood cells with it influencing around a quarter of individuals internationally.

Related Journals of Anemia

Blood Disorders & Transfusion, Anemia, Blood Cells, Molecules and Diseases.

Iron Therapy

Iron therapy id the use of oral ferrous iron salts are the most sparing and successful prescription for the treatment of iron inadequacy Anemia. Of the different iron salts accessible, ferrous sulfate is the one most ordinarily utilized. Treatment for iron deficiency concentrates on expanding your iron stores so they achieve ordinary levels and distinguishing and controlling any conditions that brought about the sickliness.

Related Journals of Iron Therapy

Blood Disorders & Transfusion, BMC Blood Disorders, Anemia, Best Practice and Research in Clinical Haematology.

Haemoglobin

Hemoglobin is the protein particle in red platelets that conveys oxygen from the lungs to the body's tissues and returns carbon dioxide from the tissues back to the lungs. Hemoglobin is additionally found outside red platelets and their begetter lines. Different cells that contain hemoglobin incorporate the A9 dopaminergic neurons in the substantia nigra, macrophages, alveolar cells, and mesangial cells in the kidney. In these tissues, hemoglobin has a non-oxygen-conveying capacity as a cell reinforcement and a controller of iron digestion system.

Related Journals of Haemoglobin

Blood Disorders & Transfusion, Best Practice and Research in Clinical Haematology, Blood cells.

Macrophages

Macrophages are important cells of the immune system that are formed in response to an infection or accumulating damaged or dead cells. Macrophages are large, specialized cells that recognize, engulf and destroy target cells. The term macrophage is formed by the combination of the Greek terms "makro" meaning big and "phagein" meaning eat.

Related Journals of Macrophages

Blood Disorders & Transfusion, Internal Medicine: Open Access, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, Pediatric Hematology/Oncology and Immunopathology.

Bone Marrow Disease

Bone marrow is the spongy tissue inside some of your bones, such as your hip and thigh bones. It contains immature cells, called stem cells. The stem cells can develop into the red blood cells that carry oxygen through your body, the white blood cells that fight infections, and the platelets that help with blood clotting. 

Related Journals of Bone Marrow Disease

Bone Reports & Recommendations, Bone Marrow Research, BMC Blood Disorders, Blood cells.

Immuoglobulins

Immunoglobulins, otherwise called antibodies, are glycoprotein atoms created by plasma cells. They act as a critical point by particularly perceiving and tying to specific antigens, for example, microorganisms or infections and helping in their devastation.. Antibodies are substances made by the body's resistant framework camera.gif in light of microscopic organisms, infections, organism, creature dander, or tumor cells. Antibodies join to the outside substances so the invulnerable framework can crush them.

Related Journals of Immuoglobulins

Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, Pediatric Hematology/Oncology and Immunopathology.

Myeloproliferative Disorders

Myeloproliferative neoplasms, or MPNs likewise called myeloproliferative Disorders, or MPDs — are a gathering of issue that are accepted to be brought on by changes in bone marrow undeveloped cells. These foundational microorganisms typically offer ascent to develop cells found in the blood flow, for example, red platelets, which convey oxygen, white platelets, which battle contamination, and platelets, which encourage blood clot.

Related Journals of Myeloproliferative Disorders

Blood Disorders & Transfusion, Clinical Lymphoma, Myeloma and Leukemia

Prothrombin Time

Prothrombin time (PT) is a blood test that measures to what extent it takes for the blood oozing to clot. A prothrombin time test can be utilized to check for draining issues. PT is additionally used to check whether drug to avoid blood clusters is working. The prothrombin time (PT) test is requested to help analyze unexplained dying, frequently alongside an incomplete thromboplastin time (PTT) test. The PT test assesses the outward and basic pathways of the coagulation course, while the PTT test assesses the inborn and normal pathways. Utilizing both looks at the incorporated capacity of the greater part of the coagulation elements.

Related Journals of Prothrombin Time

Clinical and Applied Thrombosis/Hemostasis, Journal of atherosclerosis and thrombosis, Journal of Thrombosis and Haemostasis, Journal of Thrombosis and Thrombolysis

Splenectomy Haematological Disease

A splenectomy is surgery to remove the whole spleen, a delicate estimated organ that sits under the left rib confine close to the stomach. The spleen is a vital piece of the body's safeguard framework. It contains exceptional white platelets that destroy microscopic organisms and help the body battle contaminations when you are debilitated. It likewise makes red platelets and helps remove, or channel, old ones from the body's dissemination.

Related Journals of Splenectomy Haematological Disease

Bone Marrow Transplantation, British Journal of Haematology

Thromboembolism

Thromboembolism encompasses two interrelated conditions that are part of the same spectrum, deep venous thrombosis (DVT) and pulmonary embolism (PE). The spectrum of disease ranges from clinically unsuspected to clinically unimportant to massive embolism causing death.

Related Journals of Thromboembolism

Blood Disorders & Transfusion, Blood Cells, Molecules and Diseases.

Laboratory Haemostasis

Hemostasis is generally considered regarding coagulation pathways or as a surrogate of coagulation. However, hemostasis is much more unpredictable than coagulation, which basically reflects cluster arrangement, as it consolidates a few parts random to the coagulation process.

Related Journals of Laboratory Haemostasis

Blood Disorders & Transfusion, Clinical and Applied Thrombosis/Hemostasis, Journal of Thrombosis and Haemostasis, Thrombosis and Haemostasis

Polycythemia Vera

Polycythemia vera (PV) is a stem cell disorder characterized as a hyperplastic, malignant, and neoplastic marrow disorder. Its most prominent feature is an elevated absolute red blood cell mass because of uncontrolled red blood cell production. This is a rare disorder that occurs more often in men than in women. It is not often seen in people under age 40. The problem is often linked to a gene defect called JAK2V617F. The cause of this gene defect is unknown.

Related Journals of Polycythemia Vera

Bone Marrow Research, Stem Cell Research & Therapy, Current Stem Cell Research and Therapy, Hematology/Oncology and Stem Cell Therapy, International Journal of Hematology-Oncology and Stem Cell Research

Thrombocythemia

The term "thrombocythemia" is preferred when the reason for a high platelet count isn't known. The condition infrequently is called essential or crucial thrombocythemia. This condition happens if defective cells in the bone marrow make an excess of platelets. Bone marrow is the wipe like tissue inside the bones. It contains undifferentiated cells that form into red platelets, white platelets, and platelets. What causes the bone marrow to make an excess of platelets regularly isn't known.

Related Journals of Thrombocythemia

Blood Disorders & Transfusion, Blood Cells, Molecules and Diseases

AnticoagulantsDrugs

Anticoagulants drugs and antiplatelet drugs are a type of medication that is used to eliminate or reduce the risk of blood clots. They are often called “blood thinners”. Instead, these medications help prevent or break up clots in your blood vessels or heart.

Related Journals of Anticoagulants

Blood Disorders & Transfusion, Drugs Blood Coagulation and Fibrinolysis, Blood Transfusion, Blood Purification

Myelogenous Leukemia

Acute myelogenous leukemia (AML) is a tumor of the blood and bone marrow the elastic tissue inside bones where platelets are made. Perpetual myelogenous (or myeloid or myelocytic) leukemia (CML), otherwise called constant granulocytic leukemia (CGL), is a disease of the white platelets. It is a type of leukemia portrayed by the expanded and unregulated development of transcendently myeloid cells in the bone marrow and the amassing of these cells in the blood.

Related Journals of Myelogenous Leukemia

Blood Disorders & Transfusion, Bone Marrow Research, Clinical Lymphoma, Myeloma and Leukemia, Journal of Leukemia and Lymphoma.

Sickle Erythrocytes

The strange shape and poor deformability of the sickled erythrocyte (RBC) have for the most part been considered in charge of the microvascular impediments of sickle cell disease. On the other hand, there is no relationship between the clinical seriousness of this sickness and the vicinity of sickled RBC.

Related Journals of Sickle Erythrocytes

Blood Disorders & Transfusion

B-cell Lymphoma

The B-cell lymphomas are sorts of lymphoma influencing B cells. Lymphomas are "blood diseases" in the lymph organs. They grow all the more regularly in more established grown-ups and in immunocompromised people. B-cell lymphomas incorporate both Hodgkin's lymphomas and most non-Hodgkins lymphomas. Non-Hodgkin lymphoma (NHL) is an aggregate term for a heterogeneous gathering of lymphoproliferative malignancies with varying examples of conduct and reactions to treatment. Most (ie, 80-90%) NHLs are of B-cell origin.

Related Journals of B-cell Lymphoma

Blood Disorders & Transfusion, Blood Cells, Molecules and Diseases, BMC Blood Disorders.

Lymph

The lymphatic system is a system of organs, lymph hubs, lymph channels, and lymph vessels that make and move lymph from tissues to the circulatory system. The lymph framework is a noteworthy piece of the body's resistant system. Lymph hubs make insusceptible cells that help the body battle disease. They additionally channel the lymph liquid and evacuate remote material, for example, microorganisms and growth cells.

Related Journals of Lymph

Blood Cells, Molecules and DiseasesBMC Blood Disorders.

Haematological Disorders In Children

Hematology is the study of blood cells and abnormalities of the cells and proteins (plasma). There is a wide range of hematologic disorders and diseases. In fact, since each disorder is so specialized and unique, it is sometimes the only common link between the different disorders and diseases.

Related Journals of Haematological Disorders In Children

Blood Disorders & Transfusion

Dendritic Cells

Dendritic cells are a sort of antigen-presenting cell (APC) that shape a vital part in the versatile resistant framework. The fundamental capacity of dendritic cells is to present antigens and the cells are in this way now and again alluded to as "expert" APCs. Dendritic cells are found in tissue that has contact with the outside environment, for example, the over the skin (present as Langerhans cells) and in the linings of the nose, lungs, stomach and digestion tracts.

Related Journals of Dendritic Cells

Molecular Immunology

Journal of Hematology and Thromboembolic Disorders is supporting "3rd International Conference on Hematology & Blood Disorders” during November 02-04, 2015 at Atlanta, USA.

Journal Highlights

 

Major Disease Statistics

 
*Unofficial 2015 Journal Impact Factor was established by dividing the number of articles published in 2013 and 2014 with the number of times they are cited in 2015 based on Google search and the Scholar Citation Index database. If 'X' is the total number of articles published in 2013 and 2014, and 'Y' is the number of times these articles were cited in indexed journals during 2015 then, impact factor = Y/X

Recently Published Articles

 
 
 
 
 
 
 
OMICS International Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
 
 
OMICS International Conferences 2016-17
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings
 
 

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsinc.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsinc.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsinc.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsinc.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsinc.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsinc.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsinc.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsinc.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsinc.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsinc.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@omicsinc.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsinc.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsinc.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsinc.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsinc.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsinc.com

1-702-714-7001 Extn: 9042

 
© 2008-2016 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version